Trial Profile
Assessment of beneficial effects on left ventricular hypertrophy and diastolic function by metformin in hypertensive patients with type2 DM
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2018
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Antihypercalcaemics
- Indications Hypertension; Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- 12 Apr 2018 Status changed from recruiting to completed.
- 10 Apr 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 10 Oct 2011 New trial record